Sun Pharma's Checkpoint buy: Why it's a strategic fit in the new SPIL focus

CHENNAI: India's largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 million. This strategic move significantly strengthens Sun Pharma's oncology and dermatology portfolio, aligning with its focus on high-value specialty therapies.
Despite the long-term strategic value, the market reaction on Friday surprised many, as Sun Pharma's share price fell by 1.46% at the close of the week's trading. This dip may have been driven by immediate concerns, including regulatory issues at a key manufacturing facility and the company's cautious financial guidance.
Investors are closely monitoring developments—particularly the US FDA's observations regarding Sun Pharma's Dahej facility. The company's financial performance in the coming quarters will also be under scrutiny as stakeholders assess the potential impact on its stock trajectory.
Strategic Rationale and Synergies of the Checkpoint Deal
Drug industry analysts believe the Checkpoint acquisition is a major strategic gain for Sun Pharma, which has historically grown through carefully chosen, high-potential acquisitions.
According to analysts at HDFC Securities, the deal aligns with Sun Pharma's capital allocation strategy to strengthen its specialty business. Checkpoint's Unloxcyt—a novel skin cancer drug—will serve as a complementary addition to its oncology portfolio.
In the post-Q4 earnings call, Chairman and Managing Director Dilip Shanghvi reiterated the company's commitment to expanding its specialty business.
Sun Pharma's specialty and innovative therapeutics division currently focuses on dermatology, ophthalmology, and oncology. Unloxcyt will complement existing products such as Odomzo (sonidegib) and Yonsa (abiraterone acetate)—both approved in the US—Nidlegy (awaiting approval in the EU), and the recently acquired Fibromun (in Phase III trials).
Other specialty molecules in development, including Ilumya (for psoriatic arthritis), GL0034 (obesity), MM-II (osteoarthritis), SCD-044 (atopic dermatitis/psoriasis), and Fibromun (for soft tissue sarcoma/glioblastoma), offer long-term growth potential. According to analysts, the Checkpoint acquisition is strategically significant for four key reasons:

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Hindustan Times

27 minutes ago

• Hindustan Times

Tech CEO ditches Apple Watch, mutes Bryan Johnson for better sleep: ‘Caused more stress than it solved'

A California-based CEO says he has gotten rid of his health monitoring devices and muted age-obsessed founder Bryan Johnson for better sleep and less stress. Alex Finn, the CEO and founder of Creator Buddy, feels that tracking and monitoring every aspect of life has a detrimental effect on one's health. Alex Finn, CEO of Creator Buddy, is rejecting the culture of excessive tracking and optimization. 'Got rid of my Apple Watch. Got rid of my Whop. Got rid of my Oura ring. Muted Bryan Johnson,' Finn declared on social media. 'No more sleep scores. No more recovery scores. 'Optimizing every part of my life caused more stress than it solved,' he said. According to the California-based CEO, he is sleeping better after getting rid of his Apple Watch and various other health-tracking devices and muting Bryan Johnson. Bryan's Johnson's health regime Johnson is famous for his obsession with age-reversal, a quest that sees him spending upwards of $2 million a year on a team of doctors, devices, diet plans and supplements. He follows an intensely rigorous health and longevity regimen designed to reverse his biological age and optimize every facet of his well-being. Johnson's day involves circadian-aligned light therapy, temperature check, more than 100 pills, red light therapy, a strict exercise regime, frequent health measurements through blood biomarkers, body scans etc. He has a team of over 30 experts and hundreds of data points spanning MRI, metabolic tests, genetic markers in his quest for longevity. This is not the lifestyle that Alex Finn wants for himself. 'We've gone too far' Finn believes that in the coming years, people will want to lead a good old fashioned healthy lifestyle. The culture of tracking and optimization, he says, has gone too far. 'We've gone too far and I think once people realize 90% of this bro science we are all bought into is completely made up, most people will swing back to just trying to live a good, healthy life without trying to quantify every metric of their health,' wrote the CEO of Creator Buddy. He cited a recent study claiming that glass bottles have more microplastics than plastic bottles as an example of how even the things we think are healthier can be misleading or based on flawed assumptions. 'It's all made up,' wrote Finn, adding that his new optimization routine is basically working out once in a while and not eating too much ice cream. 'Life's a lot more fun when I don't have to hit 50 benchmarks a day to convince myself I'm healthy,' he concluded.

Time of India

28 minutes ago

• Time of India

Nuvoco Vistas makes Rs 1,800 crore payment to complete Vadraj cement acquisition

Nirma Group's Nuvoco Vistas Corp has completed its acquisition of debt-ridden Vadraj Cement by making a payment of Rs 1800 crore to lenders, led by Punjab National Bank and Union Bank of India. This acquisition will boost Nuvoco Vistas' installed cement capacity by over 20%, reaching around 31 MTPA, marking its third acquisition after Lafarge Cement and Emami Cement. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Popular in Ind'l Goods/Svs 1. India Cements to sell its subsidiary Industrial Chemicals Nirma Group's Nuvoco Vistas Corp has made the Rs 1800 crore payment to lenders led by Punjab National Bank (PNB) and Union Bank of India completing its acquisition of the debt-ridden Vadraj Cement . The money was paid to lenders on Saturday, allowing them to write back their provisions this quarter, two people aware of the details said."The money came to lenders on Saturday and has been distributed. There were some delays due to some litigation but now that everything is settled, the company transferred the money well ahead of the June 24 deadline," said one of the persons cited with 25% of the more than Rs 8000 crore debt stands to gain Rs 431 crore, while Union Bank will get Rs 345 crore, calculations by ET acquisition will help Nuvoco Vistas boost its installed cement capacity by over 20% reaching around 31 MTPA and is the company's third acquisition after Lafarge Cement and Emami Cement. A Mumbai bench of the NCLT had approved the acquisition in Vadraj Cement, formerly owned by ABG Shipyard, has a 6 million tonne grinding unit in Surat and will add to Nuvoco Vistas' existing production capacity of 25 million tonne by more than 20%.The acquisition was undertaken through Vanya Corp, a wholly-owned subsidiary of Nuvoco Vistas. Subsequently, Vanya will be merged with Vadraj Cement, according to the resolution plan. Vadraj Cement will ultimately become the wholly-owned subsidiary of the Rs 1,800 crore offer outbid Adani Group at an auction under the court-monitored corporate insolvency, ET had reported in January this year. Adani group-backed Ambuja Cement had partnered with Prudent ARC-backed RKG Fund to acquire the Gujarat-based cement the Rs 1,800 crore offered by Nuvoco Vistas, Rs 1,725 crore will be used for repaying financial creditors' dues, and the balance is set aside for operational credit, dues to employees, an insolvency resolution process costs.

New Indian Express

34 minutes ago

• New Indian Express

FedEx founder Fred Smith, a Marine Corps veteran who revolutionised package delivery, dies at 80

MEMPHIS: Fred Smith, the FedEx Corp. founder who revolutionised the express delivery industry, has died, the company said. He was 80. FedEx started operating in 1973, delivering small parcels and documents more quickly than the postal service. Over the next half-century, Smith, a Marine Corps veteran, oversaw the growth of a company that became something of an economic bellwether because so many other companies rely on it. Memphis, Tennessee-based FedEx became a global transportation and logistics company that averages 17 million shipments per business day. Smith stepped down as CEO in 2022 but remained executive chairman. Smith, a 1966 graduate of Yale University, used a business theory he came up with in college to create a delivery system based on coordinated air cargo flights centered on a main hub, a "hub and spokes" system, as it became known. The company also played a major role in the shift by American business and industry to a greater use of time-sensitive deliveries and less dependence on large inventories and warehouses. Smith once told The Associated Press that he came up with the name Federal Express because he wanted the company to sound big and important when in fact it was a start-up operation with a future far from assured.